Stéphane's concern comes through in his voice on the phone.
Her 15-year-old son is one of the 6% of minors who have attention deficit disorder with or without hyperactivity (ADHD).
Every morning, he must take a Quasym capsule to stay calm during the day and be able to follow his first year professional CAP training.
But he only has two weeks of stock left.
And his dad fears the fateful moment when there won't be any left, the pharmacies around his house are dry.
The rest after this ad
“My son cannot stop his treatment overnight, which calms him down and allows him to stay focused.
Once, he had forgotten it one morning and the people around him found him euphoric, as if he were drunk,” says the forty-year-old, a pastry chef in Aisne.
Subscribe
Already subscribed?
To log in